Log in Start free →
Today’s CSR movers
SRE 4.1 ▲ 1.2
ES 3.0 ▲ 0.8
EIX 3.1 ▲ 0.8
AMZN 4.7 ▲ 0.1
GS 2.3 ▼ 0.8
WEC 2.6 ▼ 1.2
ETR 2.9 ▼ 1.2
C 2.8 ▼ 1.2
PCG 2.9 ▼ 1.2
FOX 2.4 ▼ 1.5
—
—
Health Care · NYSE NYSE · STE

Steris

$214.47 -$3.32 -1.55% CLOSE 07.20.26 AFTER HOURS $214.47
Convergence score
4.0 / 5.0 STRONG BULLISH
+0.0 vs last report
Overall valuation
Fairly Valued
Aggregated across multiple horizons
Consensus target (12mo)
$263.91 +23.1%
Range $225.00 — $295.00
Sector
Health Care
NYSE · Tracked daily
Today's snapshot

Where the signals stand.

REPORT 07.20.26
UV Convergence Score
REPORT 07.20.26
4.0
/ 5.0
STRONG BULLISH
Consensus signal A
4.0
Consensus signal B
4.0
Consensus signal D
4.0
Rating trend signal
4.2
Multi-signal aggregate How CSR works →
Day Range
$214.44 – $217.59
52W Range
$195.14 – $269.44
Volume
531.5K
Avg Vol
824.8K
Mkt Cap
$20.9B
P/E
27.05
EPS (TTM)
$7.93
Div Yield
1.16%
Beta
0.92
Today's convergence

Convergence score sits at 4.0 with overall valuation reading as fairly valued. Drivers across the horizons inform the aggregate. Open the deep dives for valuation, analyst, or financial detail.

Valuation
Fairly Valued
CSR direction
STRONG BULLISH
Last close
$214.47
Sector
Health Care
Valuation
Three horizons
UPDATED 07.20.26
Short term
0–3 MO
No target Moderate Buy
Medium term
3–12 MO
$278+29.6% Buy
Long term
12–36 MO
$213.79-0.3% Fairly Valued
Open valuation →
Analysts
Coverage & consensus
3 PANELS
Mean target (12mo)
$263.91 +23.1%
RANGE $225.00 — $295.00
Analyst consensus
Consensus rating Buy
Blended score 4.1 / 5
Analysts tracked 20
Open analysts →
Financials
Key metrics
LATEST
P/E
27.05
EPS (TTM)
$7.93
Mkt Cap
$20.9B
Div Yield
1.16%
Beta
0.92
52W Range
$195.14 – $269.44
Open financials →
Reports
Login for history

Sign in to view the historical report archive for this stock.

Log in →
Valuation breakdown

Three horizons, one consensus.

UPDATED 07.20.26
Short term
0–3 MO
Moderate Buy
Consensus target
No target available

Current analyst consensus rating from Barchart.

Medium term
3–12 MO
Buy
Consensus target
$278 +29.6%
RANGE $269 – $295
$269NOW $214.47$295

12-month analyst consensus target across covering brokerages.

Long term
12–36 MO
Fairly Valued
Consensus target
$213.79 -0.3%

UVStocks in-house sector-relative valuation model.

Signal breakdown

What’s driving the score.

EACH SIGNAL RATED 1.0 — 5.0
Top-level breakdown
Valuation: PE Ratio: 27.05PEG Ratio: -DE Ratio: -
Free Cash Flow: $837.29MPB Ratio: -PS Ratio: -Dividend: $0.63
Analyst coverage

Blended analyst consensus & targets.

3 PANELS · UPDATED 07.20.26
Analyst consensus RATING · SCORE · PANELS · ANALYSTS
Rating Blended score Panels Analysts
Buy 4.1 3 20
Price targets LOW · MEAN · MEDIAN · HIGH · UPSIDE
Coverage Low Mean Median High Upside
All panels $225.00 $263.91 $269.00 $295.00 +23.1%
Rating distribution STRONG BUY · BUY · HOLD · SELL · STRONG SELL
Coverage SB B H S SS
All panels 3 6 3 0 0
Rating trend CURRENT VS 1M / 2M / 3M
Period Rating Avg Analysts
Current Moderate Buy 4.25 8
1 Mo Ago Moderate Buy 4.25 8
2 Mo Ago Moderate Buy 4.25 8
3 Mo Ago Moderate Buy 4.25 8
Most recent analyst action LATEST DESK ACTION
Date
5/27/2026
Firm
Weiss Ratings
Action
Downgrade
Rating
Hold (C+) ➝ Hold (C)
Target
—
Related links
Financials

Full financial snapshot.

UPDATED 07.20.26
Quote snapshot 15 FIELDS
Prev Close
$217.84
Open
$217.02
Day Low
$214.44
Day High
$217.59
Bid
$211.00
Ask
$230.00
52W Low
$195.14
52W High
$269.44
50D Avg
$211.56
200D Avg
$235.56
Volume
531.5K
Avg Vol
824.8K
10D Avg Vol
714.2K
52W Change
-2.16%
S&P 52W Change
18.27%
Valuation ratios 10 FIELDS
P/E (TTM)
27.05
P/E (Fwd)
17.61
PEG (Fwd)
1.76
P/S
3.52
P/B
2.92
Book Value
$73.45
EV/Revenue
3.81
EV/EBITDA
14.14
Mkt Cap
20.9B
Enterprise Val
22.59B
Profitability & returns 6 FIELDS
Profit Margin
13.18%
Gross Margin
44.24%
Operating Margin
20.04%
EBITDA Margin
26.92%
Return on Assets
6.65%
Return on Equity
11.37%
Growth 3 FIELDS
Revenue Growth (YoY)
7.30%
Earnings Growth (YoY)
52.20%
Earnings Growth (Q)
51.20%
Balance sheet & cash flow 11 FIELDS
Total Revenue
5.94B
EBITDA
1.6B
Total Cash
439.6M
Total Debt
2.09B
Cash / Share
$4.50
Revenue / Share
$60.45
Free Cash Flow
837.29M
Operating CF
1.34B
Debt / Equity
29.00
Current Ratio
2.09
Quick Ratio
1.34
Dividend 5 FIELDS
Fwd Dividend
2.52 (1.16%)
Dividend Yield
1.16%
Payout Ratio
31.02%
5Y Avg Yield
0.90%
Ex-Div Date
2026-06-08
Share statistics 7 FIELDS
Shares Out
97.46M
Float
97.18M
Shares Short
2.34M
% Short of Float
2.41%
Short Ratio
2.64
% Held Insiders
0.31%
% Held Institutions
100.86%
Calendar & events 5 FIELDS
Next Earnings
2026-08-05
Fiscal Year End
2026-03-31
Most Recent Qtr
2026-03-31
Last Split
2:1
Split Date
1998-08-25
Company 2 FIELDS
Industry
Medical Devices
Employees
17,937